New JAHA-Published EggNest® Study and Texas State Regulatory Variance Validate Shift Toward Apron-Free Workflows in the Interventional LabMINNEAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Egg Medical today announced the publication of a prospective study in the Journal of the American Heart Association (JAHA) evaluating its EggNest Enhanced Radiation Protection Devices (ERPDs). Conducted at The Christ Hospital in Cincinnati, OH, the real-world clinical study demonstrates that radiation protection allows interventional lab personnel to perform procedures safely without heavy personal lead aprons.
Rampart Withdraws Appeal of USPTO’s Invalidation DecisionST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, 660,056 as originally granted were invalid. The USPTO’s invalidation is based on grounds that the inventions in the issued ‘056 Patent were either previously invented by, or simply obvious variants of work, by others, including Egg Medical.
Egg Medical Declares New Era in Fluoroscopy Lab Safety Following Joint Consensus StatementAs major medical societies call for mandatory adoption of Enhanced Radiation Protection Devices (ERPDs), the EggNest® Complete system emerges as the definitive solution to protect the entire clinical team
Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or DisruptionMINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Egg Medical announces the launch of EggNest™ Complete Flex, a groundbreaking advancement in radiation protection that enables clinicians to safely work apron-free or with ultralight lead aprons—without the need for construction, structural modifications or procedural downtime.
Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free ProtectionWASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that the addition of the EggNest™ system reduces levels of scatter radiation to all members of the interventional team to the extent that users could do procedures safely without the use of lead aprons or wear ultralight aprons.
